Stockreport
REGN, CI, BSX: Which “Strong Buy” Healthcare Stock Is the Best Bet? [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
intrinsic value, the healthcare scene stands out as an intriguing place to bet on. Indeed, rotating cash from scorching-hot winners into some relatively lukewarm winners that are more attractively priced can make a lot of sense. Though I would not give up on tech, I would encourage investors to be more price-selective. You don't need to pay a high-double-digit multiple for exposure to a fast grower, especially if you're willing to embrace the healthcare scene. This piece will use TipRanks' Comparison Tool to go over three healthcare stocks —REGN, CI, BSX—with Strong Buys given by the analyst community. Regeneron (NASDAQ:REGN) Regeneron is an innovative biotech firm with a large market cap ($111.3 billion) and a lofty quadruple-digit share price long overdue for a split. The company has a healthy pipeline of offerings covering various ailments, including inflammation-related diseases, ocular diseases, cancer, and liver disease. Indeed, you're covering many bases with a sizeab
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | REGN | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
REGN alerts
REGN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
REGN alerts
High impacting Regeneron Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
REGN
NEWS
NEWS
- Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting [Yahoo! Finance][Yahoo! Finance]
- The Schall Law Firm Initiates Probe Into Allegations Against Regeneron Pharmaceuticals Inc And Urges Impacted Investors To Reach Out[Accesswire]
- The Schall Law Firm Begins Investigation Into Claims Against Regeneron Pharmaceuticals Inc And Encourages Affected Investors To Connect[Accesswire]
- Axtria Announces its First Ignite Leadership Award Honorees [Yahoo! Finance][Yahoo! Finance]
- Beyond the lung: treating the GI symptoms of Covid-19 [Yahoo! Finance][Yahoo! Finance]
- More
REGN
SEC Filings
SEC Filings
- 6/20/24 - Form 8-K
- 6/17/24 - Form 4
- 6/14/24 - Form 144
- REGN's page on the SEC website
- More